This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Edith Cowan University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Pauline Zaenker: Innovator in Melanoma Diagnosis and Treatment
Introduction
Pauline Zaenker is a notable inventor based in Currambine, Australia. She has made significant contributions to the field of medical diagnostics, particularly in the area of melanoma. Her innovative work focuses on the early detection and treatment of this serious skin cancer.
Latest Patents
Zaenker holds a patent for her invention titled "Biomarkers of disease." This patent relates to methods for the diagnosis and treatment of melanoma. Specifically, it involves measuring the expression of various autoantibodies, including anti-ZBTB7B, anti-PRKCH, anti-TP53, anti-PCTK1, anti-PQBP1, anti-UBE2V1, anti-IRF4, anti-MAPK8_tv2, anti-MSN, and anti-TPM1. Additionally, her invention includes kits that comprise one or more reagents and/or devices used in performing these diagnostic methods.
Career Highlights
Zaenker is affiliated with Edith Cowan University, where she continues her research and development in the field of melanoma. Her work has garnered attention for its potential to improve early-stage diagnosis and treatment options for patients.
Collaborations
She collaborates with esteemed colleagues, including Elin Gray and Mel Ziman, who contribute to her research efforts and enhance the impact of her work.
Conclusion
Pauline Zaenker's innovative contributions to melanoma diagnosis and treatment highlight her role as a leading inventor in the medical field. Her work not only advances scientific understanding but also has the potential to save lives through early detection and intervention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile